| A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor. (NCT06305637) | Sun Pharmaceutical Industries, Inc. | 2023-12-04 |
| A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy (NCT06085664) | M.D. Anderson Cancer Center | 2023-12-04 |
| Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering (NCT05924022) | Washington State University | 2023-12-04 |
| Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers (NCT06315387) | Valenta Pharm JSC | 2023-12-04 |
| BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors (NCT06205706) | BioInvent International AB | 2023-12-04 |
| Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride (NCT06822166) | Ahon Pharmaceutical Co., Ltd. | 2023-12-04 |
| Food-Body-Mind Intervention (NCT05964218) | Michigan State University | 2023-12-03 |
| Assessment of Safety and Efficacy of SGLT2is Among LN Patients (NCT06113900) | Ain Shams University | 2023-12-01 |
| Pilot Study of a New Medical Food in the Management of Ulcerative Colitis (NCT06116643) | Stanford University | 2023-12-01 |
| A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma. (NCT06136988) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2023-12-01 |
| A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis. (NCT06175143) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2023-12-01 |
| Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease (NCT06084624) | Cairo University | 2023-12-01 |
| NV-001 in the Treatment of Advanced Solid Tumors (NCT06051760) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-12-01 |
| Montbretin Clinical Trial in Healthy Volunteers and Type 2 Diabetics (NCT05826054) | Robert Petrella | 2023-12-01 |
| Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy (NCT06187740) | Fudan University | 2023-12-01 |
| Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term (NCT05906303) | The Reading Hospital and Medical Center | 2023-12-01 |
| A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets (NCT06165822) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-12-01 |
| Psilocybin Therapy for Chronic Low Back Pain (NCT05351541) | Joshua Woolley, MD, PhD | 2023-12-01 |
| Accelerated rTMS for Post-Stroke Apathy (NCT05878457) | Medical University of South Carolina | 2023-12-01 |
| Consequence of Injectable Platelets Rich Fibrin Versus Microosteopeforation on Root Resorption During Orthodontic Intrusion of Incisor Teeth (NCT05958498) | Al-Azhar University | 2023-12-01 |
| Oral Peri-operative TIming of Metformin (or) Salsalate to Improve Non-cardiac Surgery Glucose Control (NCT03816488) | McMaster University | 2023-12-01 |
| Investigating the Effect of Obicetrapib on Lipoprotein Metabolism (NCT05972278) | NewAmsterdam Pharma | 2023-12-01 |
| Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome (NCT05886985) | BioSpring Medical Co., Ltd | 2023-12-01 |
| Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea (NCT05944965) | Brigham and Women's Hospital | 2023-12-01 |
| Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients (NCT06023212) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-12-01 |
| A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas (NCT05082493) | WPD Pharmaceuticals Sp. z o.o. | 2023-12-01 |
| BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors (NCT06120283) | BeOne Medicines | 2023-12-01 |
| Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache (NCT04580238) | University of Alberta | 2023-12-01 |
| Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia (NCT05869279) | Fondazione Matilde Tettamanti Menotti De Marchi Onlus | 2023-12-01 |
| Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus. (NCT06150651) | Chulalongkorn University | 2023-12-01 |
| A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer (NCT06165809) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-12-01 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy Volunteers (NCT04404023) | UBP Greater China (Shanghai) Co., Ltd | 2023-12-01 |
| Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT06164327) | BeBetter Med Inc | 2023-12-01 |
| Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (NCT06799637) | Evopoint Biosciences Inc. | 2023-12-01 |
| Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage (NCT06361433) | Hokkaido University Hospital | 2023-12-01 |
| A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects (NCT06175949) | Shandong Suncadia Medicine Co., Ltd. | 2023-12-01 |
| Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis (NCT04170426) | Celltex Therapeutics Corporation | 2023-12-01 |
| Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF (NCT06181370) | Agomab Spain S.L. | 2023-12-01 |
| Efficacy of Intrathecal Clonidine Versus Neostigmine as Adjuvants to Bupivacaine on Postoperative Maternal and Fetal Outcomes After Elective Cesarean Section (NCT05943613) | Assiut University | 2023-12-01 |
| An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases (NCT06093698) | ITabMed Co., Ltd. | 2023-12-01 |
| ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer (NCT05567770) | Weill Medical College of Cornell University | 2023-12-01 |
| Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors (NCT06131216) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-12-01 |
| A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (NCT06010875) | Chongqing Precision Biotech Co., Ltd | 2023-11-30 |
| Study of INKmune in Patients With mCRPC (CaRe Prostate) (NCT06056791) | Inmune Bio, Inc. | 2023-11-30 |
| A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients. (NCT07630545) | Mission Therapeutics | 2023-11-30 |
| Treatment of LSCD With DM (NCT05909735) | University of Minnesota | 2023-11-30 |
| A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects (NCT06085053) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-11-30 |
| Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult (NCT06099613) | EyeGene Inc. | 2023-11-30 |
| Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency (NCT03733067) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-11-30 |
| Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride (NCT06747520) | Ahon Pharmaceutical Co., Ltd. | 2023-11-30 |
| The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial. (NCT06140576) | Zhejiang Cancer Hospital | 2023-11-30 |
| Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma (NCT06066359) | M.D. Anderson Cancer Center | 2023-11-30 |
| PK and Safety in Participants Taking Obicetrapib With Moderate Hepatic Impairment Relative to Normal Hepatic Function (NCT06048302) | NewAmsterdam Pharma | 2023-11-30 |
| EGCG for the Prevention and Treatment of TIPN (NCT06524609) | Han Xi Zhao | 2023-11-30 |
| Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis (NCT05725057) | Artax Biopharma Inc | 2023-11-30 |
| Intraperitoneal LSTA1 in CRS-HIPEC (NCT06216561) | University of California, San Diego | 2023-11-30 |
| Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors (NCT06150183) | BioNTech SE | 2023-11-30 |
| Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias (NCT05321940) | Juan C. Ramos, MD | 2023-11-30 |
| Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma (NCT06124001) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2023-11-30 |
| Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer (NCT06105918) | Emory University | 2023-11-29 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis (NCT06166056) | Chiesi Farmaceutici S.p.A. | 2023-11-29 |
| Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions (NCT06132243) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2023-11-29 |
| Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) (NCT06162728) | Jasper Therapeutics, Inc. | 2023-11-29 |
| Study of ODX (OsteoDex) in Multiple Myeloma (NCT06616389) | DexTech Medical AB | 2023-11-29 |
| A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295 (NCT06144684) | AbbVie | 2023-11-29 |
| Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis (NCT05802056) | Mayo Clinic | 2023-11-29 |
| Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck (NCT05930951) | Groupe Oncologie Radiotherapie Tete et Cou | 2023-11-29 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects (NCT06090799) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-11-29 |
| A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants (NCT07055321) | Ethris GmbH | 2023-11-29 |
| Supporting Parents in Affirming Their Children's Experiences of Stigma (NCT05919849) | Yale University | 2023-11-29 |
| A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) (NCT06108492) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-11-28 |
| Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines (NCT06212960) | Daewoong Pharmaceutical Co. LTD. | 2023-11-28 |
| A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults (NCT05923424) | Regeneron Pharmaceuticals | 2023-11-28 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects (NCT06089837) | EicOsis Human Health Inc. | 2023-11-28 |
| 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults (NCT05890963) | David Ho | 2023-11-28 |
| A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia (NCT06185673) | Benitec Biopharma, Inc. | 2023-11-28 |
| Study of DF6215 in Patients With Advanced Solid Tumors (NCT06108479) | Dragonfly Therapeutics | 2023-11-28 |
| Treatment of AA Amyloidosis (NCT06397001) | Nelson Leung, MD | 2023-11-28 |
| A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects (NCT06159101) | Shanghai Henlius Biotech | 2023-11-28 |
| BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers (NCT06167265) | Genovate Biotechnology Co., Ltd., | 2023-11-28 |
| Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors (NCT06132828) | Zhejiang Doer Biologics Co., Ltd. | 2023-11-27 |
| A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 (NCT06147063) | AstraZeneca | 2023-11-27 |
| The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department (NCT06823154) | The Hospital for Sick Children | 2023-11-27 |
| Phase I of XKH002 Injection in Patients (NCT06196762) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2023-11-27 |
| Maximal Use Study to Determine the Pharmacokinetics of L-arginine After Exaggerated Oral Use of COL101 (NCT06182267) | Colgate Palmolive | 2023-11-27 |
| AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma (NCT05985694) | Advagene Biopharma Co. Ltd. | 2023-11-27 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors (NCT06031441) | Genentech, Inc. | 2023-11-27 |
| A Study to Evaluate Setanaxib in Patients With Alport Syndrome (NCT06274489) | Calliditas Therapeutics AB | 2023-11-27 |
| A Study of PD5K3 in Healthy Adult Volunteers (NCT06527781) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2023-11-27 |
| A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV (NCT06033209) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-11-27 |
| An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females (NCT06203444) | Ardelyx | 2023-11-27 |
| Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation (NCT05738148) | University of Alberta | 2023-11-27 |
| Study of Intravenous ZMA001 in Healthy Subjects (NCT05967299) | National Heart, Lung, and Blood Institute (NHLBI) | 2023-11-27 |
| A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer (NCT06116786) | Johnson & Johnson Enterprise Innovation Inc. | 2023-11-27 |
| A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease (NCT06154837) | GlaxoSmithKline | 2023-11-27 |
| Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults (NCT06153758) | Pfizer | 2023-11-27 |
| A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years (NCT06132789) | Ab&B Bio-tech Co., Ltd.JS | 2023-11-27 |
| ShigETEC Vaccine Study in Bangladesh (NCT05987488) | Eveliqure Biotechnologies GmbH | 2023-11-26 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers (NCT06008652) | Dren Bio | 2023-11-26 |
| A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects (NCT06162169) | Allist Pharmaceuticals, Inc. | 2023-11-25 |